We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 169 results
  1. Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

    VEGFR2 and FAK signaling pathways are interconnected and have synergistic effects on tumor angiogenesis, growth, and metastasis. Thus, instead of...

    Marwa A. Fouad, Alaa A. Osman, ... Ahmed M. El Kerdawy in BMC Chemistry
    Article Open access 12 February 2024
  2. Insilico design of an allosteric modulator targeting the protein–protein interaction site of 3 Phosphoinositide dependent Kinase-1: design, synthesis and biological activity

    The signalling pathways in human cells mostly rely on protein–protein interactions (PPI) for their function. Such a PPI site in 3 Phosphoinositide...

    Vennila Kailasam Natesan, Selvakumar Balaraman, Elango KuppannaGounder Pitchaimuthu in In Silico Pharmacology
    Article 25 September 2023
  3. Identification of potent anti-immunogenic agents through virtual screening, 3D-QSAR studies, and in vitro experiments

    A wealth of literature has highlighted the discovery of various immune modulators, frequently used in clinical practice, yet associated with numerous...

    Mamona Mushtaq, Saman Usmani, ... Zaheer Ul-Haq in Molecular Diversity
    Article 08 August 2023
  4. Molecular insight into isoform specific inhibition of PI3K-α and PKC-η with dietary agents through an ensemble pharmacophore and docking studies

    Dietary compounds play an important role in the prevention and treatment of many cancers, although their specific molecular mechanism is not yet...

    Baki Vijaya Bhaskar, Aluru Rammohan, ... Wei Gu in Scientific Reports
    Article Open access 09 June 2021
  5. Structure-based drug design and molecular dynamics studies of an allosteric modulator targeting the protein–protein interaction site of PDK1

    Context

    Protein–protein interaction interfaces play a major role in cell signaling pathways. There is always a great interest in develo**...

    Vennila Kailasam Natesan, Elango Kuppannagounder Pitchaimuthu in Journal of Molecular Modeling
    Article 26 January 2024
  6. Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery

    Zika virus (ZIKV) of the flaviviridae family, is the cause of emerging infections characterized by fever, Guillain-Barré syndrome (GBS) in adults and...

    Nikhil Pathak, Yi-** Kuo, ... **n-Moon Yang in Scientific Reports
    Article Open access 02 June 2020
  7. Targeting and ultrabroad insight into molecular basis of Resistance-nodulation-cell division efflux pumps

    Resistance-nodulation-cell devision (RND) efflux pump variants have attracted a great deal of attention for efflux of many antibiotic classes, which...

    Hooria Seyedhosseini Ghaheh, Mohammad Sadegh Damavandi, ... Seyed Hossein Hejazi in Scientific Reports
    Article Open access 27 September 2022
  8. Computational design of PD-L1 small molecule inhibitors for cancer therapy

    Drug repurposing opens new avenues in cancer therapy. Drug repurposing, or finding new uses for existing drugs, can substantially reduce drug...

    Jaikanth Chandrasekaran, Senthilkumar Elumalai, ... Panneerselvam Theivendren in Molecular Diversity
    Article 25 August 2022
  9. Computational Protein Binding

    Why it is important to know this material? The computational approach to protein binding has become a crucial methodology in drug design and...
    Chapter 2024
  10. Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis

    The BCL-2 family protein BAX is a major regulator of physiological and pathological cell death. BAX predominantly resides in the cytosol in a...

    Nadege Gitego, Bogos Agianian, ... Evripidis Gavathiotis in Nature Communications
    Article Open access 16 December 2023
  11. Discovery of small molecular inhibitors for interleukin-33/ST2 protein–protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations

    The interleukin-1 receptor like ST2 has emerged as a potential drug discovery target since it was identified as the receptor of the novel cytokine...

    Tan Thanh Mai, Phuc Gia Nguyen, ... Khac-Minh Thai in Molecular Diversity
    Article 15 January 2022
  12. SARS-CoV-2 Spike Protein: A Review of Structure, Function, Care, Vaccines, and Possible Inhibitors Designed by Molecular Modeling

    In Wuhan, Hubei Province, China, a new species of coronavirus has emerged, defined as SARS-CoV-2, which causes severe acute respiratory syndrome,...
    Tamara Alice Marinho Coelho, Rai Campos Silva, ... Carlos Henrique Tomich de Paula da Silva in Trends and Innovations in Energetic Sources, Functional Compounds and Biotechnology
    Chapter 2024
  13. Computer-Aided Drug Design: An Update

    Computer-aided drug design (CADD) approaches are playing an increasingly important role in understanding the fundamentals of ligand-receptor...
    Wenbo Yu, David J. Weber, Alexander D. MacKerell in Antibiotics
    Protocol 2023
  14. Molecular Multi-target Approach on COVID-19 for Designing Novel Chemicals

    The pandemic situation that emerged due to the SARS-CoV-2 virus has dismayed the social and economic set up badly, and still no cure is available to...
    Protocol 2021
  15. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles

    Computer-aided strategies are useful for reducing the costs and increasing the success-rate in drug discovery. Among these strategies, methods based...

    Isaias Lans, Karen Palacio-Rodríguez, ... Pilar Cossio in Journal of Computer-Aided Molecular Design
    Article Open access 12 July 2020
  16. Basic Concepts of Design of Peptide-Based Therapeutics

    Peptides are natural ligands for numerous receptors in the human body, and many of these, such as hormones, neurotransmitters, and growth factors,...
    Seetharama D. Jois in Peptide Therapeutics
    Chapter 2022
  17. Evaluation of antibacterial, antioxidant, cytotoxic, and acetylcholinesterase inhibition activities of novel [1,4] benzoxazepines fused to heterocyclic systems with a molecular modeling study

    Microbial pathogenesis, cancer progression, and neurological diseases are associated with oxidative stress due to the increased production of...

    Ahmed Al-Mustafa, Wael Al-Zereini, ... Mahmoud A. Al-Sha’er in Medicinal Chemistry Research
    Article 24 December 2022
  18. FMO-guided design of darunavir analogs as HIV-1 protease inhibitors

    The prevalence of HIV-1 infection continues to pose a significant global public health issue, highlighting the need for antiretroviral drugs that...

    Hathaichanok Chuntakaruk, Kowit Hengphasatporn, ... Supot Hannongbua in Scientific Reports
    Article Open access 13 February 2024
  19. Exploring protein hotspots by optimized fragment pharmacophores

    Fragment-based drug design has introduced a bottom-up process for drug development, with improved sampling of chemical space and increased...

    Dávid Bajusz, Warren S. Wade, ... György M. Keserű in Nature Communications
    Article Open access 27 May 2021
  20. Therapeutic strategies for identifying small molecules against prion diseases

    Prion diseases are fatal neurodegenerative disorders, for which there are no effective therapeutic and diagnostic agents. The main pathological...

    Elisa Uliassi, Lea Nikolic, ... Giuseppe Legname in Cell and Tissue Research
    Article 06 January 2022
Did you find what you were looking for? Share feedback.